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ABSTRACT: Droplet-based ﬂuidics is emerging as a powerful
platform for single cell analysis, directed evolution of enzymes,
and high throughput screening studies. Due to the small
amounts of compound compartmentalized in each droplet,
detection has been primarily by ﬂuorescence. To extend the
range of experiments that can be carried out in droplets, we
have developed the use of electrospray ionization mass
spectrometry (ESI-MS) to measure femtomole quantities of
proteins in individual pico- to nanoliter droplets. Surfactant-
stabilized droplets containing analyte were produced in a ﬂow-focusing droplet generation microﬂuidic device using ﬂuorocarbon
oil as the continuous phase. The droplets were collected oﬀ-chip for storage and reinjected into microﬂuidic devices prior to
spraying the emulsion into an ESI mass spectrometer. Crucially, high quality mass spectra of individual droplets were obtained
from emulsions containing a mixture of droplets at >150 per minute, opening up new routes to high throughput screening
studies.
Micrometer-sized aqueous droplets carried in a (ﬂuo-rocarbon) oil phase in microﬂuidic devices and
stabilized by a surfactant monolayer are emerging as a
potentially powerful technology to study compartmentalized
reactions at the picoliter to nanoliter scale.1−4 In recent years,
there has been tremendous progress in the development of
microﬂuidics-based droplet platforms for the on-chip for-
mation5,6 and manipulation of monodisperse droplets.7−12 A
suite of ﬂuorescence-based techniques can be used for high-
throughput and highly sensitive analysis of droplet contents,
enabling the picodroplets platform to be exploited in diverse
applications including single cell-based assays,13,14 and protein
expression from single copies of DNA.15 Despite the obvious
potential of ﬂuorescence-based techniques to investigate
cellular or enzymatic activity in droplets, they are limited by
the need for speciﬁc labeling of the natural substrate, sense-
partner, antigen, or probe molecule. There are many potential
applications, e.g., in proteomics and the analysis of cell-
secretion products, where ﬂuorescence is not the tool of choice,
but where mass spectrometry (MS) oﬀers unique analytical
power. This consideration prompted us to develop a robust
mass spectrometric interface to analyze proteins and peptides in
droplets.
Initial attempts to analyze individual droplet contents by
electrospray ionization mass spectrometry (ESI-MS) relied on
removing the oil carrier phase via on-chip de-emulsiﬁcation by
extracting sample droplets from the oil phase into a continuous
aqueous ﬂow interfaced with ESI-MS.16−19 Subsequently, there
have been a number of advances in mass spectrometric analysis
of plugs, generated in capillaries with or without series of T-
junctions for the addition of further reagents and directly
interfaced with a mass spectrometer,20−22 or of droplets,
generated in microﬂuidic devices with on-chip electrospray
ionization emitter and containing HPLC eﬄuent and
proteolysis buﬀer.23 However, no advances to date have
reported the recording of mass spectra from individual
surfactant-stabilized droplets. This is extremely important
because the full potential of droplet technology in many
applications can only be realized by the use of large numbers of
stable droplets that can be manipulated and stored for extended
time periods.24 Thus, surfactant-stabilized droplets are required
that can be injected into a device that interfaces with the mass
spectrometer at the appropriate time. In this paper, we describe
for the ﬁrst time how femtomole quantities of proteins
compartmentalized in individual surfactant-stabilized pico- to
nanoliter droplets can be analyzed by spraying a remotely
generated droplet emulsion directly into a mass spectrometer.
Received: February 11, 2013
Accepted: March 20, 2013
Published: March 20, 2013
Letter
pubs.acs.org/ac
© 2013 American Chemical Society 3812 dx.doi.org/10.1021/ac400453t | Anal. Chem. 2013, 85, 3812−3816
■ RESULTS AND DISCUSSION
Choice of Oils and Surfactants for Direct Droplet
Injection. The choice of the continuous phase and appropriate
surfactant is important in microdroplet ESI-MS, not least
because they exist in high concentration in relation to the
analytes of interest. Fluorous oils and surfactants, with their
characteristically strong electron withdrawing properties,
should signiﬁcantly reduce their ionization in positive ion
mode. Initial scoping studies on bradykinin (5 μM) in
Novec7500, FC-40, and FC-77 showed signiﬁcant noise
(Supporting Information, S4), which could be suppressed by
the addition of PFOH (1H,1H,2H,2H-perﬂuorooctan-1-ol).
Even when lowering the concentration of bradykinin to 100
nM (in perﬂuorooctane containing 30% [vol/vol] PFOH) and
injecting 833 pL of (80 attomole of bradykinin) droplets, the
ion current of the major charge state of bradykinin species
(BkH2)
2+ from a single scan was very strong and clearly showed
individual droplets (see Supporting Information, S5).
Mass Spectrometry on Individual, Surfactant-Stabi-
lized Droplets. Unfortunately, the preferred surfactant for
stable droplets, a Krytox-Jeﬀamine triblock copolymer (see
Figure 2: PEG-PFPE, in ref 13; commercially available as
PicoSurf-2 (Sphere Fluidics Ltd.)) signiﬁcantly reduced the
noise from the oil but also strongly suppressed the bradykinin
signal (Supporting Information, S1). Nevertheless, we were
able to record high quality mass spectra from individual
picoliter droplets by producing droplets of diameter ca. 107 μm
(650 pL) containing a high concentration of α-chymotrypsi-
nogen A (50 μM) at a frequency of 171 Hz in a ﬂow-focusing
droplet generation module using Novec 7500 containing 2% w/
w PicoSurf-2 as the continuous phase. These droplets, each
containing approximately 32.5 fmol of protein, were collected
oﬀ-chip and the stable emulsion was stored overnight at 4 °C.
Subsequently, droplets were reinjected at a ﬂow rate of 50 nL/
min into a microﬂuidic emitter device using Novec 7500 as the
spacing oil at a ﬂow rate of 167 nL/min (Figure 1a). Figure 1b
shows a 21 s section of the total ion current (TIC)
chromatogram of positive ion MS, with a droplet reinjection
frequency of ca. 1.6 Hz, recorded at a scan rate of 11.1 Hz (0.08
s scan duration and 0.01 s interscan delay, V-mode time-of-
ﬂight, TOF) and using a capillary voltage of 2.54 kV. At these
ﬂow rates, the so-called nanoelectrospray ionization (nano-
ESI)25 regime, the direct injection of the biphasic ﬂow into the
mass spectrometer, leads to rises in the TIC each time
individual droplets are emitted from the device. Signiﬁcantly,
the peaks for the droplets are well-separated as the TIC drops
to a minimum during the injection of the oil phase, consistent
with a signiﬁcant reduction in the eﬃciency of ionization from
sprayed oil. Each peak in the TIC chromatogram of Figure 1b
consists of 3−5 scans of an individual droplet. The colored dots
represent the single scan spectra presented in Figure 1c. These
individual scans are remarkably free of interfering signals of the
oil phase and clearly show the emergence of the signal for the
protein α-chymotrypsinogen A (25 666 Da) as well as its rapid
disappearance. Importantly, each of the scans containing the
protein allows an accurate mass for the protein to be
determined; the ﬁgures show the deconvoluted masses
obtained from the single scan, which are all close to the
expected mass of α-chymotrypsinogen A.
Injection of a Cocktail of Droplets. To demonstrate that
mass spectrometry could be used to distinguish between
diﬀerent proteins in diﬀerent droplets, 104−114 μm diameter
(593−778 pL) droplets were produced from solutions of four
diﬀerent proteins, each droplet population containing 25 μM of
protein (14.8−19.5 fmol of analyte in each droplet). These
droplets were collected oﬀ-chip and stored overnight at 4 °C.
Aliquots (8.0 μL) of each protein emulsion were then mixed to
create a cocktail containing the four individual protein droplets
(Figure 2a). For mass spectrometric analysis, the droplet
Figure 1. (a) Picoliter droplets containing α-chymotrypsinogen A (50 μM) were generated at 171 Hz in a ﬂow-focusing droplet generation module.
The droplets were collected oﬀ-chip, and the emulsion was stored overnight at 4 °C. For mass spectrometric analysis, droplets were reinjected into
the emitter device. (b) 21 s section of TIC. The colored dots correspond to the individual scans of α-chymotrypsinogen A and are shown in (c).
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cocktail was reinjected at a ﬂow rate of 66.7 nL/min into the
microﬂuidic emitter device using FC-3283 containing 2% w/w
PicoSurf-2 surfactant (133.3 nL/min) as the spacing oil (Figure
2b). Analysis was carried out at a high scan rate of the MS
(positive ion, V-mode for TOF, 0.05 s scan duration, 0.01 s
interscan delay, scan rate of 16.7 Hz), enabling the four
individual proteins in separate droplets, and in random order,
to be observed and resolved at 2.6 Hz. Figure 2c shows the
individual ion currents for the major charge states for each of
the proteins; the quality of the single scan spectra allow each
protein to be identiﬁed easily. It can be seen that these four ion
currents collectively form the TIC in Figure 2d, showing
remarkably stable periodic increases for 86 droplets over 33 s
and over 551 scans. These data indicate that the signal strength
could be used to estimate the amount of analyte in each
droplet, although a quantitative analysis is beyond the scope of
this paper. On the basis of the ﬂow rate and the duration of the
scan, we estimate that a mass spectrum is obtained from a
volume of approximately 200 pL, containing a maximum of 5
femtomole of protein.
Figure 2. (a) Four populations of droplets containing either cytochrome C, α-chymotrypsinogen A, carbonic anhydrase, or chicken lysozyme (each
25 μM) were generated in a ﬂow-focusing droplet generation module. The droplets were collected oﬀ-chip and stored at 4 °C overnight. Aliquots of
each protein emulsion were then mixed to create a cocktail containing the four individual protein droplets. (b) The droplet cocktail was reinjected
into the emitter device connected to the ESI-MS. (c) Individual scans of droplets containing cytochrome C (scan 513), carbonic anhydrase (scan
529), chicken lysozyme (scan 533), and α-chymotrypsinogen A (scan 539) respectively. (d) The TIC (551 scans, 33 s of data) and ion currents for
86 droplets recorded at m/z ranges 2851−2854, 2909−2918, 1788−1790, and 1748−1750 corresponding to the major charge states of α-
chymotrypsinogen A, carbonic anhydrase, chicken lysozyme, and cytochrome C,, respectively.
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Careful analysis of the mass spectra during injection of the oil
in Figure 2d (Supporting Information, Figure S6) shows a
range of peaks that can be attributed to surfactant molecules
(see Supporting Information). In addition to surfactant ions, we
also see residual traces of proteins, which indicate that some
cause cross-contamination of the following droplet probably
due to incomplete spraying of the sample before the next
droplet arrives at the emitter, as we see no evidence of droplet
fusion and proteins cannot diﬀuse through the oil phase in
surfactant-stabilized emulsions.26 The addition of surfactant-
free spacing oil during the reinjection of droplets into the MS
chip will improve the recording from single droplets.
Detection of Antibodies. Finally, we explored the limits of
the technique with respect to the nature of the detected protein
and the sensitivity of detection. As the molecular weight of
proteins increases above 100 kDa, they become progressively
more diﬃcult to characterize by mass spectrometry. We
therefore addressed this challenge by studying the antibody
Trastuzumab (Herceptin) in droplets. Trastuzumab (hIgG1)
exhibits a degree of microheterogeneity as a result of post-
translational glycosylation, however, a raw molecular weight has
recently been calculated at 148 057 Da.27 This microheter-
ogeneity of the glycoprotein sample should make the derivation
of a molecular weight even more challenging from a single
picodroplet. Trastuzumab-containing droplets (12.5 μM, 410
pL, 92 μm diameter, ca. 5.1 fmol antibody per droplet) were
formed at a frequency of 134 Hz in a ﬂow focusing droplet
generation module using 2% w/w PicoSurf-2 surfactant in
FC3283 and stored overnight at 4 °C. The droplets were
reinjected into a microﬂuidic emitter chip (250 nL/min), with
FC3283 (333 nL/min) as the spacing oil. Figure 3a shows the
detection of individual droplets (MS conﬁgured in positive ion
V-mode for TOF, with a sample cone voltage of 3.67 kV, 0.05 s
scan duration, and 0.01 s interscan delay (scan rate 16.7 Hz)).
Despite the large molecular mass of the analyte, single scan ESI
MS spectra (Figure 3b, left) from individual droplets show ﬁve
charge states, similar to the mass spectrum obtained from
Trastuzumab sprayed under normal conditions (Figure 3c, left).
Charge state deconvolution (using settings of minimal mass of
100 kDa and maximum of 200 kDa and a resolution of 0.125
Da/channel) from single scan spectrum obtained from a single
droplet (scan 4561, containing around 5 femtomole of analyte)
leads to a measured molecular weight for the antibody of 147.6
± 0.016 kDa (Figure 3b, right), well within the expected mass
range for the diﬀerent glycosylated forms and very similar to
the number obtained for Trastuzumab sprayed in a conven-
tional manner into the ESI MS (147.7 ± 0.042 kDa, Figure 3c,
right).
■ CONCLUSION
We have demonstrated, for the ﬁrst time, that it is possible to
record high resolution mass spectra of individual surfactant-
stabilized droplets containing subfemtomole amounts of
proteins at scan rates of (10 Hz). The method is robust and
can be applied to droplets as small as several hundred picoliter
to several nanoliters, with a few femtomoles of analyte in
droplets, and molecular weights of 1 to >100 kDa. The label-
free detection of very small amounts of antibodies and other
proteins in stabilized droplets will aid in the development in
new assays, e.g., to detect the chemical modiﬁcation of proteins.
With further reﬁnement of the technology, we believe that mass
spectrometry on individual droplets oﬀers a unique tool to not
only directly study the secretion of molecules (cytokines,
antibodies) from compartmentalized cells but also study their
cytosolic constituents as well, following cell lysis.
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